The present invention relates to a solid unit dosage form for oral administration (tablet or granules) containing non-crystalline selexipag in a polymeric matrix. The solid dispersion is prepared by hot-melt extrusion, whereby the milled extrudate is subsequently subjected to a dry-granulation process.
